vimarsana.com

Latest Breaking News On - Disease assessment scale cognitive - Page 5 : vimarsana.com

BioVie Announces Efficacy Data from Phase 3 Trial of

Why Is Alzheimer s-Focused BioVie (BIVI) Stock Trading Lower Today? - BioVie (NASDAQ:BIVI)

BioVie Inc (NASDAQ: BIVI) shares are trading lower after the company released an analysis of unblinded, topline efficacy data from its Phase 3 trial of NE3107 for mild to 

BioVie Announces Efficacy Data from Phase 3 Trial of NE3107 in Patients with Mild to Moderate Alzheimer s Disease

29.11.2023 - Positive Trending Data from 57 Per-Protocol Patients Suggest NE3107 is Biologically Active and May Have Impact on Cognitive, Functional, and Biomarker Endpoints Sponsor Identified Issues Relating to Significant GCP Violations and Protocol .

Cassava Sciences: Likely Potential Opportunity From Phase 3 Readout (NASDAQ:SAVA)

Cassava Sciences: Likely Potential Opportunity From Phase 3 Readout (NASDAQ:SAVA)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.